Large Cap Biopharma Earnings Boost Stocks: Update Tuesday, Aug 1

Stocks were broadly higher in July after financial reports. Now that earnings are in, track technicals and potential clinical catalysts for August/September which can be weak seasonally.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.